Almaral

Moncyte Health is a personalized medicine company focused on advancing the treatment and prevention of cardiovascular disease, particularly high cholesterol. The company has developed patented technology that enables a cellular mechanism analysis test designed to identify patients who may not respond effectively to traditional statin treatments. This innovative approach allows healthcare providers to make informed, data-driven decisions tailored to individual patient needs, ultimately aiming to enhance treatment outcomes in the management of high cholesterol.

Fepod is a healthcare technology company that specializes in developing an electrochemical analysis tool designed to accurately measure the blood concentration of medications such as paracetamol and opioids. The company's innovative solution features mass-producible, disposable sampling sensors that are compatible with an affordable and portable analytical device, which can be connected to a standard smartphone. This technology aims to enhance patient care by providing healthcare professionals with the means to make quick and informed decisions regarding medication management, ultimately facilitating improved and personalized treatment for patients.

Marginum is a university-based medical technology startup focused on developing fluorescence-based tissue detection systems aimed at enhancing cancer treatment. The company leverages data-driven technologies to improve the identification of cancer cells during surgeries, ultimately facilitating better surgical performance and greater cost-effectiveness in healthcare. By collaborating closely with academic, clinical, and industrial experts, Marginum ensures that its innovative solutions are seamlessly compatible with clinical applications, advancing the field of oncology through state-of-the-art research and technology.

Seppo, a Finnish start-up, specializes in game-based learning through its interactive platform that harnesses mobile technology to enhance corporate training, strategy communication, and change management. The platform allows users to create gamified solutions that go beyond simple quizzes, fostering deep analysis, collaboration, and self-reflection among participants. The game environments can be diverse, including 360-degree images, 3D worlds, or real-life settings, and all features can be utilized without the need for coding. Powered by artificial intelligence, Seppo enables users to transform training materials into engaging games in just minutes. The platform also includes a large content library filled with ready-made games. Seppo operates on an automated recurring SaaS business model, generating substantial annual recurring revenue.

Fepod is a healthcare technology company that specializes in developing an electrochemical analysis tool designed to accurately measure the blood concentration of medications such as paracetamol and opioids. The company's innovative solution features mass-producible, disposable sampling sensors that are compatible with an affordable and portable analytical device, which can be connected to a standard smartphone. This technology aims to enhance patient care by providing healthcare professionals with the means to make quick and informed decisions regarding medication management, ultimately facilitating improved and personalized treatment for patients.